nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpropamide—ABCC8—forebrain—attention deficit hyperactivity disorder	0.0435	0.0803	CbGeAlD
Chlorpropamide—KCNJ11—cardiovascular system—attention deficit hyperactivity disorder	0.0399	0.0737	CbGeAlD
Chlorpropamide—ABCC8—cardiovascular system—attention deficit hyperactivity disorder	0.0368	0.0679	CbGeAlD
Chlorpropamide—ABCC8—midbrain—attention deficit hyperactivity disorder	0.0287	0.053	CbGeAlD
Chlorpropamide—KCNJ11—nervous system—attention deficit hyperactivity disorder	0.0256	0.0473	CbGeAlD
Chlorpropamide—KCNJ11—central nervous system—attention deficit hyperactivity disorder	0.0247	0.0455	CbGeAlD
Chlorpropamide—KCNJ11—cerebellum—attention deficit hyperactivity disorder	0.0241	0.0445	CbGeAlD
Chlorpropamide—ABCC8—nervous system—attention deficit hyperactivity disorder	0.0236	0.0436	CbGeAlD
Chlorpropamide—ABCC8—central nervous system—attention deficit hyperactivity disorder	0.0227	0.042	CbGeAlD
Chlorpropamide—ABCC8—cerebellum—attention deficit hyperactivity disorder	0.0222	0.041	CbGeAlD
Chlorpropamide—SLC22A6—brain—attention deficit hyperactivity disorder	0.0207	0.0383	CbGeAlD
Chlorpropamide—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A9—attention deficit hyperactivity disorder	0.02	0.0437	CbGpPWpGaD
Chlorpropamide—KCNJ11—brain—attention deficit hyperactivity disorder	0.0196	0.0362	CbGeAlD
Chlorpropamide—ABCC8—Regulation of insulin secretion—ADRA2C—attention deficit hyperactivity disorder	0.0186	0.0407	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A9—attention deficit hyperactivity disorder	0.0186	0.0406	CbGpPWpGaD
Chlorpropamide—KCNJ11—Regulation of insulin secretion—ADRA2C—attention deficit hyperactivity disorder	0.0181	0.0394	CbGpPWpGaD
Chlorpropamide—ABCC8—brain—attention deficit hyperactivity disorder	0.018	0.0333	CbGeAlD
Chlorpropamide—PTGS1—forebrain—attention deficit hyperactivity disorder	0.0178	0.0328	CbGeAlD
Chlorpropamide—SLC15A2—midbrain—attention deficit hyperactivity disorder	0.0172	0.0317	CbGeAlD
Chlorpropamide—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.0164	0.0303	CbGeAlD
Chlorpropamide—PTGS1—cardiovascular system—attention deficit hyperactivity disorder	0.015	0.0277	CbGeAlD
Chlorpropamide—ABCC8—Integration of energy metabolism—ADRA2C—attention deficit hyperactivity disorder	0.0146	0.032	CbGpPWpGaD
Chlorpropamide—KCNJ11—Integration of energy metabolism—ADRA2C—attention deficit hyperactivity disorder	0.0142	0.031	CbGpPWpGaD
Chlorpropamide—SLC15A2—nervous system—attention deficit hyperactivity disorder	0.0141	0.026	CbGeAlD
Chlorpropamide—SLC15A2—central nervous system—attention deficit hyperactivity disorder	0.0136	0.0251	CbGeAlD
Chlorpropamide—SLC15A2—cerebellum—attention deficit hyperactivity disorder	0.0133	0.0245	CbGeAlD
Chlorpropamide—ABCC8—Regulation of insulin secretion—CACNB2—attention deficit hyperactivity disorder	0.0129	0.0281	CbGpPWpGaD
Chlorpropamide—KCNJ11—Regulation of insulin secretion—CACNB2—attention deficit hyperactivity disorder	0.0125	0.0272	CbGpPWpGaD
Chlorpropamide—ABCC8—Regulation of insulin secretion—CACNA1C—attention deficit hyperactivity disorder	0.0118	0.0257	CbGpPWpGaD
Chlorpropamide—KCNJ11—Regulation of insulin secretion—CACNA1C—attention deficit hyperactivity disorder	0.0114	0.0249	CbGpPWpGaD
Chlorpropamide—SLC15A2—brain—attention deficit hyperactivity disorder	0.0108	0.0199	CbGeAlD
Chlorpropamide—ABCB1—forebrain—attention deficit hyperactivity disorder	0.0105	0.0194	CbGeAlD
Chlorpropamide—ABCC8—Regulation of insulin secretion—SNAP25—attention deficit hyperactivity disorder	0.0103	0.0224	CbGpPWpGaD
Chlorpropamide—ABCC8—Integration of energy metabolism—CACNB2—attention deficit hyperactivity disorder	0.0101	0.0221	CbGpPWpGaD
Chlorpropamide—KCNJ11—Regulation of insulin secretion—SNAP25—attention deficit hyperactivity disorder	0.00997	0.0218	CbGpPWpGaD
Chlorpropamide—KCNJ11—Integration of energy metabolism—CACNB2—attention deficit hyperactivity disorder	0.0098	0.0214	CbGpPWpGaD
Chlorpropamide—ABCC8—Regulation of insulin secretion—ADRA2A—attention deficit hyperactivity disorder	0.00978	0.0214	CbGpPWpGaD
Chlorpropamide—PTGS1—nervous system—attention deficit hyperactivity disorder	0.00964	0.0178	CbGeAlD
Chlorpropamide—KCNJ11—Regulation of insulin secretion—ADRA2A—attention deficit hyperactivity disorder	0.00949	0.0207	CbGpPWpGaD
Chlorpropamide—PTGS1—central nervous system—attention deficit hyperactivity disorder	0.00928	0.0171	CbGeAlD
Chlorpropamide—ABCC8—Integration of energy metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00924	0.0202	CbGpPWpGaD
Chlorpropamide—ABCC8—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00897	0.0196	CbGpPWpGaD
Chlorpropamide—KCNJ11—Integration of energy metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00896	0.0196	CbGpPWpGaD
Chlorpropamide—SLC15A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00895	0.0195	CbGpPWpGaD
Chlorpropamide—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00887	0.0164	CbGeAlD
Chlorpropamide—KCNJ11—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00869	0.019	CbGpPWpGaD
Chlorpropamide—SLC15A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00831	0.0181	CbGpPWpGaD
Chlorpropamide—ABCC8—Integration of energy metabolism—SNAP25—attention deficit hyperactivity disorder	0.00808	0.0176	CbGpPWpGaD
Chlorpropamide—KCNJ11—Integration of energy metabolism—SNAP25—attention deficit hyperactivity disorder	0.00784	0.0171	CbGpPWpGaD
Chlorpropamide—ABCC8—Integration of energy metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00769	0.0168	CbGpPWpGaD
Chlorpropamide—KCNJ11—Integration of energy metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00746	0.0163	CbGpPWpGaD
Chlorpropamide—PTGS1—brain—attention deficit hyperactivity disorder	0.00737	0.0136	CbGeAlD
Chlorpropamide—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00693	0.0128	CbGeAlD
Chlorpropamide—SLC22A6—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00617	0.0135	CbGpPWpGaD
Chlorpropamide—ABCB1—nervous system—attention deficit hyperactivity disorder	0.0057	0.0105	CbGeAlD
Chlorpropamide—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00549	0.0101	CbGeAlD
Chlorpropamide—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00536	0.00989	CbGeAlD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00505	0.011	CbGpPWpGaD
Chlorpropamide—CYP2C19—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00489	0.0107	CbGpPWpGaD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00482	0.0105	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00472	0.0103	CbGpPWpGaD
Chlorpropamide—ABCC8—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00459	0.01	CbGpPWpGaD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00455	0.00993	CbGpPWpGaD
Chlorpropamide—KCNJ11—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00445	0.00972	CbGpPWpGaD
Chlorpropamide—ABCB1—brain—attention deficit hyperactivity disorder	0.00435	0.00804	CbGeAlD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00434	0.00948	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00422	0.00922	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00403	0.00879	CbGpPWpGaD
Chlorpropamide—ABCC8—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00395	0.00862	CbGpPWpGaD
Chlorpropamide—PTGS1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00384	0.00839	CbGpPWpGaD
Chlorpropamide—KCNJ11—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00383	0.00836	CbGpPWpGaD
Chlorpropamide—ABCC8—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00367	0.00801	CbGpPWpGaD
Chlorpropamide—KCNJ11—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00356	0.00777	CbGpPWpGaD
Chlorpropamide—ABCC8—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00327	0.00714	CbGpPWpGaD
Chlorpropamide—KCNJ11—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00317	0.00692	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00313	0.00684	CbGpPWpGaD
Chlorpropamide—SLC15A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00312	0.0068	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00299	0.00653	CbGpPWpGaD
Chlorpropamide—SLC15A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00289	0.00631	CbGpPWpGaD
Chlorpropamide—ABCC8—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00278	0.00607	CbGpPWpGaD
Chlorpropamide—ABCC8—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00276	0.00603	CbGpPWpGaD
Chlorpropamide—KCNJ11—Neuronal System—COMT—attention deficit hyperactivity disorder	0.0027	0.00589	CbGpPWpGaD
Chlorpropamide—KCNJ11—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00268	0.00585	CbGpPWpGaD
Chlorpropamide—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00222	0.00484	CbGpPWpGaD
Chlorpropamide—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00215	0.00469	CbGpPWpGaD
Chlorpropamide—PTGS1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00206	0.00449	CbGpPWpGaD
Chlorpropamide—PTGS1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00204	0.00446	CbGpPWpGaD
Chlorpropamide—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00202	0.00441	CbGpPWpGaD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00176	0.00384	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00167	0.00366	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00162	0.00354	CbGpPWpGaD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00158	0.00346	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00147	0.00321	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00143	0.00312	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00136	0.00297	CbGpPWpGaD
Chlorpropamide—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00119	0.00259	CbGpPWpGaD
Chlorpropamide—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00118	0.00257	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00117	0.00255	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00116	0.00252	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00116	0.00252	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00114	0.00248	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00112	0.00245	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00112	0.00245	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—DPYD—attention deficit hyperactivity disorder	0.0011	0.00241	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00109	0.00238	CbGpPWpGaD
Chlorpropamide—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00108	0.00236	CbGpPWpGaD
Chlorpropamide—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00107	0.00234	CbGpPWpGaD
Chlorpropamide—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00107	0.00233	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00107	0.00233	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00106	0.00231	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00103	0.00224	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00102	0.00222	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000924	0.00202	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000896	0.00196	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00088	0.00192	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000853	0.00186	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000841	0.00184	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—COMT—attention deficit hyperactivity disorder	0.0007	0.00153	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000695	0.00152	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—COMT—attention deficit hyperactivity disorder	0.000679	0.00148	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000674	0.00147	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00058	0.00127	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00058	0.00127	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000571	0.00125	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000531	0.00116	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000497	0.00108	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000485	0.00106	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000473	0.00103	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000464	0.00101	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000456	0.000996	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000442	0.000965	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000442	0.000964	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000352	0.000767	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000349	0.000762	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000339	0.000739	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000335	0.00073	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000335	0.00073	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000329	0.000719	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000327	0.000713	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000327	0.000713	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000321	0.000701	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000306	0.000668	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000305	0.000666	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000305	0.000666	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—EP300—attention deficit hyperactivity disorder	0.0003	0.000656	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.0003	0.000655	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000299	0.000652	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—EP300—attention deficit hyperactivity disorder	0.000291	0.000636	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000279	0.000609	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000267	0.000584	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000261	0.00057	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000255	0.000556	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000249	0.000543	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000244	0.000532	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000232	0.000507	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	0.000203	0.000442	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000201	0.000439	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000198	0.000432	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000196	0.000429	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000195	0.000426	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000185	0.000403	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000184	0.000401	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000178	0.000389	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000151	0.000329	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	8.69e-05	0.00019	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	8.48e-05	0.000185	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	7.93e-05	0.000173	CbGpPWpGaD
